320 related articles for article (PubMed ID: 28110254)
21. Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer.
Lee E; Keam B; Kim DW; Kim TM; Lee SH; Chung DH; Heo DS
J Thorac Oncol; 2013 Aug; 8(8):1069-74. PubMed ID: 23804027
[TBL] [Abstract][Full Text] [Related]
22. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
Morris PG; Reiner AS; Szenberg OR; Clarke JL; Panageas KS; Perez HR; Kris MG; Chan TA; DeAngelis LM; Omuro AM
J Thorac Oncol; 2012 Feb; 7(2):382-5. PubMed ID: 22089116
[TBL] [Abstract][Full Text] [Related]
23. Nimotuzumab treatment and outcome analysis in patients with leptomeningeal metastasis from nonsmall cell lung cancer.
Ju Y; Wang J; Sun S; Jiao S
J Cancer Res Ther; 2016 Dec; 12(Supplement):C181-C185. PubMed ID: 28230014
[TBL] [Abstract][Full Text] [Related]
24. Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments.
Ozcan G; Singh M; Vredenburgh JJ
Clin Cancer Res; 2023 Jan; 29(1):11-29. PubMed ID: 35972437
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and Security of Intrathecal with Methotrexate in the Treatment of Meningeal Carcinomatosis].
Wu X; Li J; Xiao J; Yang B; Yu L; Wu X; Wan J; Xu H; Kong J
Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):252-6. PubMed ID: 27215452
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.
Beauchesne P
Lancet Oncol; 2010 Sep; 11(9):871-9. PubMed ID: 20598636
[TBL] [Abstract][Full Text] [Related]
28. Successful EGFR-TKI rechallenge of leptomeningeal carcinomatosis after gefitinib-induced interstitial lung disease.
Nakamichi S; Kubota K; Horinouchi H; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Tamura T
Jpn J Clin Oncol; 2013 Apr; 43(4):422-5. PubMed ID: 23410901
[TBL] [Abstract][Full Text] [Related]
29. Focusing on Intrathecal Pemetrexed for Treating Leptomeningeal Metastases From NSCLC.
Pan Z
J Thorac Oncol; 2022 Mar; 17(3):e31-e32. PubMed ID: 35216736
[No Abstract] [Full Text] [Related]
30. [Clinical features and prognostic factors in patients with leptomeningeal metastases].
Li N; Yang BY; Li JL; Zhu JQ; Zou BH; Wang YF; Yu L; Yao XY
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):867-70. PubMed ID: 24447488
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
32. [Leptomeningeal carcinomatosis as a rare metastatic spreading of BRAF-mutated microsatellite stable colon cancer].
Höblinger A; Weber S; Tschirner F; Kröber S; Streetz K
Z Gastroenterol; 2017 Jul; 55(7):667-674. PubMed ID: 28709170
[TBL] [Abstract][Full Text] [Related]
33. LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancer.
Arrondeau J; Ammari S; Besse B; Soria JC
J Thorac Oncol; 2014 Aug; 9(8):e62-3. PubMed ID: 25157781
[No Abstract] [Full Text] [Related]
34. Response to Letter to the Editor Titled "Focusing on Intrathecal Pemetrexed for Treating Leptomeningeal Metastases from NSCLC?".
Fan C; Zhao Q; Teng C; Jiang Z; Xin T
J Thorac Oncol; 2022 Mar; 17(3):e33-e34. PubMed ID: 35216737
[No Abstract] [Full Text] [Related]
35. Management of neoplastic meningitis.
Roth P; Weller M
Chin Clin Oncol; 2015 Jun; 4(2):26. PubMed ID: 26112812
[TBL] [Abstract][Full Text] [Related]
36. Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.
Ou SH; Sommers KR; Azada MC; Garon EB
Oncologist; 2015 Feb; 20(2):224-6. PubMed ID: 25568147
[TBL] [Abstract][Full Text] [Related]
37. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Salgia S; Fleming GF; Lukas RV
J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
[TBL] [Abstract][Full Text] [Related]
38. Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations.
Alexander M; Lin E; Cheng H
Curr Treat Options Oncol; 2020 Jul; 21(9):72. PubMed ID: 32725549
[TBL] [Abstract][Full Text] [Related]
39. Leptomeningeal metastases of solid cancer.
Le Rhun E; Galanis E
Curr Opin Neurol; 2016 Dec; 29(6):797-805. PubMed ID: 27661208
[TBL] [Abstract][Full Text] [Related]
40. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
Sipőcz I; Pintér T; Skaliczky Z; Kullmann T
Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
